SPONSORSHIP
Support the future of orthopaedic outcomes data
Clinician participation and Special Interest Groups (SIG) can be funded by practice groups, philanthropic organisations, hospitals, and device manufacturers, who recognise the value of systematic, independently administered outcome data.
Sponsoring participation in OrthoCompass provides evidence generating infrastructure that is structured, documented, and is at arm's-length, with an established legitimate purpose.
What sponsors support
OrthoCompass, the outcomes platform.
Collects, reports, and benchmarks patient outcomes across all musculoskeletal procedures, connected to your practice management system.
PROPELLER, the national registry.
Pseudonymised data from all contributors, enabling benchmarking from day one.
EBM Analytics, the service layer.
Daily list processing, chart review, and patient contact, so the surgeon's job is to use the data, not produce it.
Who can be sponsors
Sponsorship is open to two types of organisations, funding the same program for different reasons.
Practice Groups and Hospitals
Invest in your surgeons. Measure what you do.
A complete, benchmarked picture of outcomes across everything your surgeons do, including what existing registries don't capture.
Quality infrastructure: demonstrate to regulators, insurers, and patients that quality is measurable.
Research enablement: longitudinal data as the foundation for grants, publications, and collaborations.
Talent attraction: outcomes infrastructure surgeons can't build alone.
Device Manufacturers
Real-world evidence. Compliant engagement. Global utility.
Existing national registries don't capture non-arthroplasty procedures, sub-revision complications, or patient-reported recovery with individual feedback to the surgeon.
OrthoCompass-PROPELLER does, collected independently and structured for post-market surveillance.
Real-world evidence across all procedures your devices support, including indications not typically captured.
MTAA-compliant engagement with a documented legitimate purpose, independent selection, and arm's-length administration.
Global regulatory utility that is relevant to FDA, Health Canada, PMDA, and EMA-aligned teams via TGA's IMDRF alignment.
For soft-tissue procedures, and the full range of upper limb hardware, PROPELLER with data collected by OrthoCompass is the only structured real-world evidence pipeline available in Australia at this level of granularity with the potential for national coverage. Existing national registries do not capture these indications.
How it works
01
Selection criteria agreed in writing, in collaboration with the sponsor.
02
Sign a Sponsor Agreement that documents the purpose, selection criteria, fees, and governance.
03
Participants onboarded are identified and engaged independently by EBM Analytics, each under their own Participant Agreement.
04
Program commences when OrthoCompass is configured and daily processing begins, PROPELLER connection active immediately.
Governance
What sponsors can expect:
-
Data is reported in aggregate in a centralised location (website) with versioning. Summary outputs are provided and broken down by pre-defined groupings (e.g. diagnosis/indication) where appropriate
-
In some cases data may be suppressed if insufficient samples are available to alleviate risk of re-identification
-
-
The scope of reporting differs between SIG and individual sponsored arrangements
-
Sponsors of a Special Interest Group receive access to aggregate reports of the entire group and pre-defined subgroups
-
Sponsors of individual clinicians receive less detailed information under an opt-in process from the contributing clinician
-
-
Reporting schedules are typically quarterly but can be customised depending on needs
-
Additional analyses can be organised with specialised queries on registry data which must be made by formal request to be reviewed by the Registry Advisory Panel and undergo external HREC approval where required